- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Long Beach, California, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
- Novo Nordisk Investigational Site Atlanta, Georgia, United States
Clinical trial condition
Congenital Bleeding Disorder
Explore clinical trials studying Congenital Bleeding Disorder. Study availability and eligibility vary by location and protocol.
85 public trials
0 recruiting studies
Congenital Bleeding Disorder trial results
NCT02490787
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Torrance, California, United States
- Novo Nordisk Investigational Site Indianapolis, Indiana, United States
- Novo Nordisk Investigational Site Iowa City, Iowa, United States
- Novo Nordisk Investigational Site Baltimore, Maryland, United States
NCT01876745
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
Completed
Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors
NCT01392547
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Clinical Trial Call Center Tucson, Arizona, United States
- Novo Nordisk Clinical Trial Call Center Los Angeles, California, United States
- Novo Nordisk Clinical Trial Call Center Los Angeles, California, United States
- Novo Nordisk Clinical Trial Call Center Orange, California, United States
Completed
Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A
NCT01138501
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Orange, California, United States
- Novo Nordisk Investigational Site Torrance, California, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
NCT00840086
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Little Rock, Arkansas, United States
- Novo Nordisk Investigational Site Long Beach, California, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
- Novo Nordisk Investigational Site Atlanta, Georgia, United States
NCT00486278
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
- Locations
-
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Augusta, Georgia, United States
- Novo Nordisk Investigational Site Chicago, Illinois, United States
- Novo Nordisk Investigational Site Indianapolis, Indiana, United States
NCT01586936
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
NCT01555749
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
- Locations
-
- Novo Nordisk Investigational Site Harrow, United Kingdom
NCT01230021
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Locations
-
- Novo Nordisk Investigational Site Boston, Massachusetts, United States
- Novo Nordisk Investigational Site Detroit, Michigan, United States
- Novo Nordisk Investigational Site Minneapolis, Minnesota, United States
- Novo Nordisk Investigational Site Columbus, Ohio, United States